Prognostic value of pressure-flow study in surgical treatment of benign prostatic obstruction

被引:42
|
作者
Gotoh, M [1 ]
Yoshikawa, Y [1 ]
Kondo, AS [1 ]
Kondo, A [1 ]
Ono, Y [1 ]
Ohshima, S [1 ]
机构
[1] Nagoya Univ, Sch Med, Dept Urol, Showa Ku, Nagoya, Aichi 4668550, Japan
关键词
urodynamics; benign prostatic obstruction;
D O I
10.1007/s003450050145
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The prognostic Value of pressure-flow study (P-FS) in the surgical treatment of bladder outlet obstruction (BOO) was retrospectively studied in patients with benign prostatic hyperplasia. In 74 patients who underwent surgical treatment for BOG, P-FS and free uroflowmetry were performed pre- and postoperatively. On P-FS, obstruction and detrusor contractility were analyzed according to the Schafer nomogram. The patients were classified into the following 3 groups according to their preoperative P-FS: group A consisted of 39 patients with normal detrusors and obstruction (obstruction grade 3-6); group B consisted of 13 patients with weak detrusors and obstruction; and group C included 22 patients with weak or very weak detrusors combined with minimal obstruction, if any (obstruction grade 0-2). Postoperatively, the detrusor pressure at maximal flow tate and obstruction grades on P-FS improved significantly in groups A and B but not in group C. The rate of improvement was most prominent in group A, followed by groups B and C. On free uroflowmetry, however, a significant improvement occurred in all three groups with respect to maximal flow rate, average flow rate, and postvoid residue. Moreover, the rate did not differ among the three groups except for the maximal flow rate as determined between groups A and C. Although good detrusor contractility and evident obstruction on analysis of P-FS will guarantee the best surgical outcome, subjects with weak detrusors and minimal obstruction will also have a good outcome by the relief of BOG. In the weak detrusor, P-FS may be limited in diagnosing obstruction and have a low prognostic value, and such patients should not necessarily be excluded from surgical indications.
引用
收藏
页码:274 / 278
页数:5
相关论文
共 50 条
  • [41] Australian surgical revision rates for benign prostatic obstruction
    Jain, Anika
    Nassour, Anthony-Joe
    Woo, Henry
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 12 - 12
  • [42] Australian surgical revision rate for benign prostatic obstruction
    Jain, Anika
    Nassour, Anthony-Joe
    Khannani, Hadia
    Wines, Michael P.
    Chalasani, Venu
    Katelaris, Phillip
    Bergersen, Philip
    Symons, James L.
    Baskaranathan, Sris
    Woo, Henry
    BJU INTERNATIONAL, 2023, 131 : 43 - 47
  • [43] The role of urodynamics in the surgical management of benign prostatic obstruction
    Crockett, Matthew G.
    Drake, Marcus J.
    CURRENT OPINION IN UROLOGY, 2018, 28 (03) : 267 - 272
  • [45] Emerging drugs for the treatment of benign prostatic obstruction
    Hashim, Hashim
    Abrams, Paul
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (02) : 159 - 174
  • [46] Emerging treatment options for benign prostatic obstruction
    Parsons B.A.
    Hashim H.
    Current Urology Reports, 2011, 12 (4) : 247 - 254
  • [47] Electrovaporization of the prostate versus laser ablation of the prostate in men with benign prostatic hypertrophy: A pressure-flow analysis
    Shingleton, WB
    Kolski, J
    Renfroe, DL
    Fowler, JE
    UROLOGIA INTERNATIONALIS, 1998, 60 (04) : 224 - 228
  • [48] Correlations between parameters in pressure-flow analysis and histological compositions in prostate in patients with benign prostatic hyperplasia
    Ichiyanagi, O
    Nakada, T
    UROLOGIA INTERNATIONALIS, 1997, 59 (03) : 154 - 160
  • [49] Surgical Treatment of benign Prostatic Syndrome
    Gratzke, C.
    Stief, C. G.
    UROLOGE, 2013, 52 (03): : 329 - 330
  • [50] Surgical treatment options of lower urinary tract symptoms due to benign prostatic obstruction
    Magistro, Giuseppe
    Abt, S. Dominik
    Becher, Klaus F.
    Bschleipfer, Thomas
    Dreikorn, Kurt
    Hoefner, Klaus
    Muschter, Rolf
    Oelke, Matthias
    Reich, Oliver
    Salem, Johannes
    Schoenburg, Sandra
    Madersbacher, Stephan
    Rieken, Malte
    UROLOGIE, 2023, 62 (11): : 1215 - 1216